The prognostic significance of concomitant statin use in cancer treatment with immune checkpoint inhibitors (ICIs) remains a subject of ongoing investigation. This study aims to clarify the prognostic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback